721 related articles for article (PubMed ID: 27401536)
21. Effectiveness of breast-specific gamma imaging (BSGI) for breast cancer in Korea: a comparative study.
Lee A; Chang J; Lim W; Kim BS; Lee JE; Cha ES; Moon BI
Breast J; 2012 Sep; 18(5):453-8. PubMed ID: 22897514
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic performance of breast-specific gamma imaging in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients.
Lee HS; Ko BS; Ahn SH; Son BH; Lee JW; Kim HJ; Yu JH; Kim SB; Jung KH; Ahn JH; Cha JH; Kim HH; Lee HJ; Song IH; Gong G; Park SH; Lee JJ; Moon DH
Breast Cancer Res Treat; 2014 May; 145(1):91-100. PubMed ID: 24671359
[TBL] [Abstract][Full Text] [Related]
23. Breast-specific gamma imaging influences surgical management in patients with breast cancer.
Edwards C; Williams S; McSwain AP; Damle S; Rapelyea JA; Downs K; Torrente J; Sambamurty A; Brem RF; Teal CB
Breast J; 2013; 19(5):512-9. PubMed ID: 23848225
[TBL] [Abstract][Full Text] [Related]
24. Breast-Specific γ-Imaging for the Detection of Mammographically Occult Breast Cancer in Women at Increased Risk.
Brem RF; Ruda RC; Yang JL; Coffey CM; Rapelyea JA
J Nucl Med; 2016 May; 57(5):678-84. PubMed ID: 26823569
[TBL] [Abstract][Full Text] [Related]
25. Breast-specific gamma imaging with 99mTc-Sestamibi and magnetic resonance imaging in the diagnosis of breast cancer--a comparative study.
Brem RF; Petrovitch I; Rapelyea JA; Young H; Teal C; Kelly T
Breast J; 2007; 13(5):465-9. PubMed ID: 17760667
[TBL] [Abstract][Full Text] [Related]
26. Breast-specific gamma imaging with Tc-99m-sestamibi in the diagnosis of breast cancer and its semiquantitative index correlation with tumor biologic markers, subtypes, and clinicopathologic characteristics.
Tan H; Zhang H; Yang W; Fu Y; Gu Y; Du M; Cheng D; Shi H
Nucl Med Commun; 2016 Aug; 37(8):792-9. PubMed ID: 27058361
[TBL] [Abstract][Full Text] [Related]
27. Breast-specific gamma imaging is a cost effective and efficacious imaging modality when compared with MRI.
Johnson N; Sorenson L; Bennetts L; Winter K; Bryn S; Johnson W; Glissmeyer M; Garreau J; Blanchard D
Am J Surg; 2014 May; 207(5):698-701; discussion 701. PubMed ID: 24791629
[TBL] [Abstract][Full Text] [Related]
28. Clinical utility of breast-specific gamma imaging for evaluating disease extent in the newly diagnosed breast cancer patient.
Zhou M; Johnson N; Gruner S; Ecklund GW; Meunier P; Bryn S; Glissmeyer M; Steinbock K
Am J Surg; 2009 Feb; 197(2):159-63. PubMed ID: 19185109
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.
Comstock CE; Gatsonis C; Newstead GM; Snyder BS; Gareen IF; Bergin JT; Rahbar H; Sung JS; Jacobs C; Harvey JA; Nicholson MH; Ward RC; Holt J; Prather A; Miller KD; Schnall MD; Kuhl CK
JAMA; 2020 Feb; 323(8):746-756. PubMed ID: 32096852
[TBL] [Abstract][Full Text] [Related]
30. Adjunctive Breast-Specific Gamma Imaging for Detecting Cancer in Women with Calcifications at Mammography.
Chung HW; So Y; Yang JH; Park KS; Yoo YB; Choi N; Kim MY; Kim J; Lee EJ
Ann Surg Oncol; 2017 Nov; 24(12):3541-3548. PubMed ID: 28819909
[TBL] [Abstract][Full Text] [Related]
31. Breast-specific gamma imaging: correlations with mammographic and clinicopathologic characteristics of breast cancer.
Park JY; Yi SY; Park HJ; Kim MS; Kwon HJ; Park NH; Moon SY
AJR Am J Roentgenol; 2014 Jul; 203(1):223-8. PubMed ID: 24951219
[TBL] [Abstract][Full Text] [Related]
32. Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography.
Hata T; Takahashi H; Watanabe K; Takahashi M; Taguchi K; Itoh T; Todo S
J Am Coll Surg; 2004 Feb; 198(2):190-7. PubMed ID: 14759774
[TBL] [Abstract][Full Text] [Related]
33. Effects of age, breast density and volume on breast cancer diagnosis: a retrospective comparison of sensitivity of mammography and ultrasonography in China's rural areas.
Wang FL; Chen F; Yin H; Xu N; Wu XX; Ma JJ; Gao S; Tang JH; Lu C
Asian Pac J Cancer Prev; 2013; 14(4):2277-82. PubMed ID: 23725127
[TBL] [Abstract][Full Text] [Related]
34. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging.
Menell JH; Morris EA; Dershaw DD; Abramson AF; Brogi E; Liberman L
Breast J; 2005; 11(6):382-90. PubMed ID: 16297080
[TBL] [Abstract][Full Text] [Related]
35. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
[TBL] [Abstract][Full Text] [Related]
36. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
[TBL] [Abstract][Full Text] [Related]
37. Breast scintigraphy with breast-specific γ-camera in the detection of ductal carcinoma in situ: a correlation with mammography and histologic subtype.
Spanu A; Sanna D; Chessa F; Cottu P; Manca A; Madeddu G
J Nucl Med; 2012 Oct; 53(10):1528-33. PubMed ID: 22911882
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of feature analysis of breast-specific gamma imaging for predicting malignancy.
Choi EK; Im JJ; Park CS; Chung YA; Kim K; Oh JK
Eur Radiol; 2018 Dec; 28(12):5195-5202. PubMed ID: 29948076
[TBL] [Abstract][Full Text] [Related]
39. Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography.
Papantoniou V; Tsiouris S; Mainta E; Valotassiou V; Souvatzoglou M; Sotiropoulou M; Nakopoulou L; Lazaris D; Louvrou A; Melissinou M; Tzannetaki A; Pirmettis I; Koutsikos J; Zerva C
Breast Cancer Res; 2005; 7(1):R33-45. PubMed ID: 15642168
[TBL] [Abstract][Full Text] [Related]
40. Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings.
Collarino A; de Koster EJ; Valdés Olmos RA; de Geus-Oei LF; Pereira Arias-Bouda LM
Clin Breast Cancer; 2018 Feb; 18(1):9-18. PubMed ID: 28728876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
